Vivanza Biosciences opened lower at ₹1.45, compared with its previous close of ₹1.47. In the last trading session on 12 Nov 2026, the stock traded between ₹1.45 and ₹1.50, with an average traded price of ₹1.48. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Vivanza Biosciences is now worth
₹ 766.00
Resulting in a loss of
₹ 9,234.00 (92.34%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.01 (+0.68%)
Day High
₹1.50
Day Low
₹1.45
Day Open
₹1.45
Prev Close
₹1.47
Volume
17,527
Value Traded
₹0.00 Cr
1W Return
8.82%
1M Return
-12.43%
3M Return
-21.28%
6M Return
-25.63%
1Y Return
-25.25%
Market Cap (₹ Cr.)
6
PE Ratio
147.00
PB Ratio
1.27
Dividend Yield
-
ROE
9.05%
ROCE
15.72%
Book Value (₹)
1.16
Face Value (₹)
1.00
EPS (TTM)
0.03
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
8.82%
6 Weeks
-
1 Month
-12.43%
3 Months
-21.28%
9 Months
-29.52%
Vivanza Biosciences Q2FY27 Results: Net profit drops 92% YoY to ₹3.6 lakh
Standalone net profit dropped 92% YoY to ₹3.58 lakh in Q2FY27. Revenue from operations fell 79% YoY to ₹1,129.82 lakh. Trade receivables doubled to ₹1,904.50 lakh, signaling collection pressure. Operating cash flow turned negative at ₹244.70 lakh for H1FY27.
6 days agoVivanza Biosciences cites low capital to skip RPT disclosure for Q2FY27
Vivanza Biosciences Limited stated that Regulation 23(9) disclosure is not applicable for Q2FY27. Paid-up equity share capital stood at ₹4 crore as on March 31, 2026. Net worth was reported at ₹4.39 crore, falling below the ₹25 crore threshold. The company committed to complying with RPT disclosures within six months if thresholds are breached.
14 days agoVivanza Biosciences closes trading window ahead of Q2FY27 results
Trading window closed from October 1, 2026. Closure lasts until 48 hours post-Q2FY27 results declaration. Applies to Designated Persons and connected persons per SEBI regulations.
1mo agoVivanza Biosciences shareholders approve all AGM resolutions with near-unanimous support
Vivanza Biosciences shareholders approved all nine resolutions at its 44th AGM on September 11, 2026. Borrowing limit increases and director appointments received 99.99% to 100% support. All voting occurred via remote e-voting through NSDL between September 8 and 10, 2026. Material related party transactions for FY27 were approved with 99.52% support.
2mo agoVivanza Biosciences schedules 44th AGM for September 11, 2026
Vivanza Biosciences Limited has scheduled its 44th Annual General Meeting (AGM) for Friday, September 11, 2026, at 3:30 pm via VC/OAVM. The primary agenda includes adopting audited financials for FY26, which show a turnaround to a net profit of ₹37.50 lakh on revenue of ₹11,234.04 lakh. Shareholders will also vote on special resolutions for borrowing limits up to ₹100 crore and board reappointments.
2mo agoVivanza Biosciences Q1 Results: Unaudited financials filed for June 2026
Vivanza Biosciences Limited filed unaudited Q1FY27 results on August 8, 2026, approved by the Board on August 7. The filing complies with SEBI Regulation 47 and includes a notice regarding the extended special window for dematerializing physical shares until February 4, 2027.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,896.40 | +0.60% | ₹4,55,009.88 | 41.20 | +9.49% | |
| ₹11,503.00 | +0.16% | ₹3,05,368.51 | 90.40 | +76.43% | |
| ₹4,686.00 | -0.87% | ₹1,78,240.38 | 85.50 | +22.52% | |
| ₹2,432.80 | +1.37% | ₹1,31,447.16 | 97.10 | +145.92% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.50 | +0.14% | ₹1,15,895.36 | 42.00 | +12.92% | |
| ₹1,408.80 | +0.04% | ₹1,13,811.10 | 39.90 | -7.27% | |
| ₹2,665.50 | +1.02% | ₹1,10,097.17 | 48.10 | +17.42% | |
| ₹1,814.80 | +0.42% | ₹1,04,419.58 | 26.00 | +53.33% | |
| ₹2,019.00 | +0.20% | ₹92,326.85 | 17.60 | -0.73% | |
| ₹2,641.50 | -0.69% | ₹74,549.65 | 51.60 | +42.95% | |
| ₹5,182.50 | -2.25% | ₹61,964.56 | 30.50 | -10.14% |
An investment of ₹10,000 made 5 years ago in Vivanza Biosciences is now worth
₹ 766.00
Resulting in a loss of
₹ 9,234.00 (92.34%)
Note: Past profits do not guarantee future returns.
